Shijiazhuang Yiling Pharmaceutical Co: Net profit grew 7.25% year-over-year in Q1 2025 despite a 6.52% revenue drop

About this update from Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A

Q1 2025 saw net profit rise 7.25% year-over-year to RMB 325.95 million despite a 6.52% revenue decline, with strong operating cash flow and improved core profitability. Asset impairment and reduced government subsidies were notable headwinds.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A